Communique from the Annual General Meeting of AlzeCure Pharma on 29 June 2026

About this update from Alzecure Pharma Ab

STOCKHOLM, SE / ACCESS Newswire / June 29, 2026 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - Today, 29 June 2026, the annual general meeting was held in AlzeCure Pharma AB (publ) (the "Company"). Below is a summary of the resolutions made. All resolutions were passed with the required majority. Resolution regarding the adoption of the accounts and allocation of the Company's result The annual general meeting resolved to adopt the profit and loss statement and the balance sheet. The annual general meeting also resolved to allocate the Company's result in accordance with the board of directors' and the CEO's proposal, meaning that no dividend is paid to the shareholders, and that available funds are carried forward. Discharge from liability for the members of the board of directors and the managing director The annual general meeting resolved to grant discharge from liability to the members of the board of directors and the managing director for the financial year 2025. Election of and remuneration to the board of directors and the auditor The annual general meeting resolved, in accordance with the nomination committees' proposal, on re-election of Ragnar Linder, Janet Hoogstraate, Eva Lilienberg and Jan Lundberg as ordinary members of the board of directors. Eggert Mörling was, in accordance with the nomination committee's proposal, elected as a new member of the board, and as chairman of the board of directors. Thomas Pollare has declined re-election. The annual general meeting further resolved that the remuneration to the board of directors shall be SEK 400,000 to the chairman and SEK 200,000 to each of the other board members who are not employed by the Company. The annual general meeting also resolved to, in accordance with the nomination committees' proposal, re-elect Grant Thornton AB as auditor and that the auditor shall be paid according to approved invoice. Grant Thornton AB has announced that the certified accountant Camilla Nilsson will be the auditor in charge. Resolution on the approval of the remuneration report The annual general meeting resolved to approve the board of director's remuneration report in accordance with Chapter 8, Section 53 a of the Swedish Companies Act. Authorisation for the board of directors to resolve on new issues The annual general meeting resolved, in accordance with the board of directors' proposal, to authorise the bo...

View stock analysis, news, and events for Alzecure Pharma Ab